Literature DB >> 22133303

Identification of DNA methylation changes associated with human gastric cancer.

Jung-Hoon Park1, Jinah Park, Jung Kyoon Choi, Jaemyun Lyu, Min-Gyun Bae, Young-Gun Lee, Jae-Bum Bae, Dong Yoon Park, Han-Kwang Yang, Tae-You Kim, Young-Joon Kim.   

Abstract

BACKGROUND: Epigenetic alteration of gene expression is a common event in human cancer. DNA methylation is a well-known epigenetic process, but verifying the exact nature of epigenetic changes associated with cancer remains difficult.
METHODS: We profiled the methylome of human gastric cancer tissue at 50-bp resolution using a methylated DNA enrichment technique (methylated CpG island recovery assay) in combination with a genome analyzer and a new normalization algorithm.
RESULTS: We were able to gain a comprehensive view of promoters with various CpG densities, including CpG Islands (CGIs), transcript bodies, and various repeat classes. We found that gastric cancer was associated with hypermethylation of 5' CGIs and the 5'-end of coding exons as well as hypomethylation of repeat elements, such as short interspersed nuclear elements and the composite element SVA. Hypermethylation of 5' CGIs was significantly correlated with downregulation of associated genes, such as those in the HOX and histone gene families. We also discovered long-range epigenetic silencing (LRES) regions in gastric cancer tissue and identified several hypermethylated genes (MDM2, DYRK2, and LYZ) within these regions. The methylation status of CGIs and gene annotation elements in metastatic lymph nodes was intermediate between normal and cancerous tissue, indicating that methylation of specific genes is gradually increased in cancerous tissue.
CONCLUSIONS: Our findings will provide valuable data for future analysis of CpG methylation patterns, useful markers for the diagnosis of stomach cancer, as well as a new analysis method for clinical epigenomics investigations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133303      PMCID: PMC3273443          DOI: 10.1186/1755-8794-4-82

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


  53 in total

Review 1.  Genetic susceptibility and gastric cancer risk.

Authors:  Carlos A González; Núria Sala; Gabriel Capellá
Journal:  Int J Cancer       Date:  2002-07-20       Impact factor: 7.396

2.  A full genome scan for gastric cancer.

Authors:  M Aoki; K Yamamoto; H Noshiro; K Sakai; J Yokota; T Kohno; T Tokino; S Ishida; S Ohyama; I Ninomiya; K Uesaka; M Kitajima; S Shimada; S Matsuno; M Yano; M Hiratsuka; H Sugimura; F Itoh; T Minamoto; Y Maehara; S Takenoshita; T Aikou; H Katai; K Yoshimura; T Takahashi; K Akagi; M Sairenji; Y Yamamura; T Sasazuki
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

3.  Ataxia-telangiectasia and stomach cancer.

Authors:  M Massad; S Uthman; S Obeid; F Majjar
Journal:  Am J Gastroenterol       Date:  1990-05       Impact factor: 10.864

4.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells.

Authors:  Michael Weber; Jonathan J Davies; David Wittig; Edward J Oakeley; Michael Haase; Wan L Lam; Dirk Schübeler
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

5.  CpG islands in vertebrate genomes.

Authors:  M Gardiner-Garden; M Frommer
Journal:  J Mol Biol       Date:  1987-07-20       Impact factor: 5.469

6.  The p53-mdm-2 autoregulatory feedback loop.

Authors:  X Wu; J H Bayle; D Olson; A J Levine
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

7.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

8.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

9.  Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer.

Authors:  Tibor Rauch; Gerd P Pfeifer
Journal:  Lab Invest       Date:  2005-09       Impact factor: 5.662

10.  MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.

Authors:  Chun-Ling Jiang; Seung-Gi Jin; Gerd P Pfeifer
Journal:  J Biol Chem       Date:  2004-09-28       Impact factor: 5.157

View more
  23 in total

1.  DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy.

Authors:  Wen Quan Jonathan Goh; Ghim Siong Ow; Vladimir A Kuznetsov; Shirly Chong; Yoon Pin Lim
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.

Authors:  Yu Mi Woo; Jae-Bum Bae; Yeon-Hee Oh; Young-Gun Lee; Min Joo Lee; Eun Young Park; Jung-Kyoon Choi; Sunyoung Lee; Yubin Shin; Jaemyun Lyu; Hye-Yoon Jung; Yeon-Su Lee; Young-Hwan Hwang; Young-Joon Kim; Jong Hoon Park
Journal:  Hum Genet       Date:  2013-10-16       Impact factor: 4.132

Review 3.  The wayward methyl group and the cascade to cancer.

Authors:  Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-03-20       Impact factor: 4.534

Review 4.  Deciphering the epigenetic code: an overview of DNA methylation analysis methods.

Authors:  Muhammad Umer; Zdenko Herceg
Journal:  Antioxid Redox Signal       Date:  2013-01-22       Impact factor: 8.401

5.  Serotonin transporter gene methylation is associated with hippocampal gray matter volume.

Authors:  Udo Dannlowski; Harald Kugel; Ronny Redlich; Adriane Halik; Ilona Schneider; Nils Opel; Dominik Grotegerd; Kathrin Schwarte; Christiane Schettler; Oliver Ambrée; Stephan Rust; Katharina Domschke; Volker Arolt; Walter Heindel; Bernhard T Baune; Thomas Suslow; Weiqi Zhang; Christa Hohoff
Journal:  Hum Brain Mapp       Date:  2014-05-23       Impact factor: 5.038

6.  Identification of key miRNA-gene pairs in gastric cancer through integrated analysis of mRNA and miRNA microarray.

Authors:  Tieming Zhu; Qiuyue Lou; Zhewei Shi; Ganghong Chen
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 7.  How to stomach an epigenetic insult: the gastric cancer epigenome.

Authors:  Nisha Padmanabhan; Toshikazu Ushijima; Patrick Tan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

8.  FAT4 hypermethylation and grade dependent downregulation in gastric adenocarcinoma.

Authors:  Maryam Pilehchian Langroudi; Novin Nikbakhsh; Ali Akbar Samadani; Sadegh Fattahi; Hassan Taheri; Shahryar Shafaei; Galia Amirbozorgi; Reza Pilehchian Langroudi; Haleh Akhavan-Niaki
Journal:  J Cell Commun Signal       Date:  2016-10-01       Impact factor: 5.782

9.  A GG allele of 3'-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer.

Authors:  Xiaoting Wang; Youdong Lin; Fenghua Lan; Yinghao Yu; Xuenong Ouyang; Xuzhou Wang; Qiaojia Huang; Lie Wang; Jianming Tan; Feng Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-16       Impact factor: 4.553

10.  microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8.

Authors:  Na Yu; Peiwei Huangyang; Xiaohan Yang; Xiao Han; Ruorong Yan; Hongti Jia; Yongfeng Shang; Luyang Sun
Journal:  J Biol Chem       Date:  2013-05-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.